- Home
- BME vs CION Comparison
BME vs CION Comparison
Compare BME & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BME
- CION
- Stock Information
- Founded
- BME 2005
- CION 2011
- Country
- BME United States
- CION United States
- Employees
- BME N/A
- CION N/A
- Industry
- BME Trusts Except Educational Religious and Charitable
- CION Finance/Investors Services
- Sector
- BME Finance
- CION Finance
- Exchange
- BME Nasdaq
- CION Nasdaq
- Market Cap
- BME 525.3M
- CION 593.9M
- IPO Year
- BME N/A
- CION N/A
- Fundamental
- Price
- BME $40.21
- CION $12.49
- Analyst Decision
- BME
- CION Hold
- Analyst Count
- BME 0
- CION 2
- Target Price
- BME N/A
- CION $12.25
- AVG Volume (30 Days)
- BME 34.0K
- CION 223.4K
- Earning Date
- BME 01-01-0001
- CION 03-13-2025
- Dividend Yield
- BME 6.26%
- CION 12.18%
- EPS Growth
- BME N/A
- CION 50.69
- EPS
- BME 1.44
- CION 1.48
- Revenue
- BME N/A
- CION $254,537,000.00
- Revenue This Year
- BME N/A
- CION $1.10
- Revenue Next Year
- BME N/A
- CION N/A
- P/E Ratio
- BME $28.37
- CION $8.46
- Revenue Growth
- BME N/A
- CION 3.26
- 52 Week Low
- BME $35.53
- CION $10.52
- 52 Week High
- BME $43.20
- CION $12.69
- Technical
- Relative Strength Index (RSI)
- BME 50.67
- CION 76.69
- Support Level
- BME $40.01
- CION $11.42
- Resistance Level
- BME $40.55
- CION $12.50
- Average True Range (ATR)
- BME 0.38
- CION 0.21
- MACD
- BME -0.11
- CION 0.09
- Stochastic Oscillator
- BME 17.09
- CION 90.04
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies.